Literature DB >> 12074708

Genotyping of human killer-cell immunoglobulin-like receptor genes by polymerase chain reaction with sequence-specific primers: an update.

N Gómez-Lozano1, Carlos Vilches.   

Abstract

Killer-cell Immunoglobulin-like Receptors (KIR) help human natural killer (NK) cells counteract infections by pathogens that evade the immune system by inducing down-regulation of HLA class I molecules in infected cells. KIRs are structural and functionally diverse receptors encoded by a family of polymorphic genes. The most extreme aspect of KIR polymorphism is the varying content of KIR-genes in the genome of different individuals, as first demonstrated by KIR genotyping using the PCR-SSP method. Knowledge on the KIR-gene family has been recently expanded by the identification of new genes, pseudogenes and multiple gene variants, several of which escaped detection by the original genotyping technique. We present here an upgraded PCR-SSP method for KIR genotyping that integrates recent achievements in the research of the diversity of this gene family. Our method permits detection of all known KIR genes and pseudogenes in a 16-reaction set. Furthermore, an additional set of six reactions permits subtyping of KIR2DL5 variants, each of which shows well-differentiated functional and genetic features.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12074708     DOI: 10.1034/j.1399-0039.2002.590302.x

Source DB:  PubMed          Journal:  Tissue Antigens        ISSN: 0001-2815


  34 in total

1.  Killer cell immunoglobulin-like receptors (KIR) typing by DNA sequencing.

Authors:  Lihua Hou; Minghua Chen; Noriko Steiner; Kanthi Kariyawasam; Jennifer Ng; Carolyn K Hurley
Journal:  Methods Mol Biol       Date:  2012

2.  Promoter variants of KIR2DL5 add to diversity and may impact gene expression.

Authors:  Tiernan J Mulrooney; LiHua Hou; Noriko K Steiner; Minghua Chen; Ian Belle; Jennifer Ng; Carolyn Katovich Hurley
Journal:  Immunogenetics       Date:  2008-05-07       Impact factor: 2.846

3.  Diversity of killer cell immunoglobulin-like receptor genes in Pacific Islands populations.

Authors:  Marija Velickovic; Zlatibor Velickovic; Heather Dunckley
Journal:  Immunogenetics       Date:  2006-05-30       Impact factor: 2.846

4.  High KIR diversity in Amerindians is maintained using few gene-content haplotypes.

Authors:  Ketevan Gendzekhadze; Paul J Norman; Laurent Abi-Rached; Zulay Layrisse; Peter Parham
Journal:  Immunogenetics       Date:  2006-05-05       Impact factor: 2.846

5.  Defining KIR and HLA Class I Genotypes at Highest Resolution via High-Throughput Sequencing.

Authors:  Paul J Norman; Jill A Hollenbach; Neda Nemat-Gorgani; Wesley M Marin; Steven J Norberg; Elham Ashouri; Jyothi Jayaraman; Emily E Wroblewski; John Trowsdale; Raja Rajalingam; Jorge R Oksenberg; Jacques Chiaroni; Lisbeth A Guethlein; James A Traherne; Mostafa Ronaghi; Peter Parham
Journal:  Am J Hum Genet       Date:  2016-08-04       Impact factor: 11.025

6.  African Americans exhibit a predominant allele in the midst of extensive KIR2DL1 allelic diversity.

Authors:  L Hou; M Chen; B Jiang; J Ng; C K Hurley
Journal:  Tissue Antigens       Date:  2010-03-01

7.  Asian population frequencies and haplotype distribution of killer cell immunoglobulin-like receptor (KIR) genes among Chinese, Malay, and Indian in Singapore.

Authors:  Yi Chuan Lee; Soh Ha Chan; Ee Chee Ren
Journal:  Immunogenetics       Date:  2008-07-31       Impact factor: 2.846

8.  Killer cell immunoglobulin-like receptor (KIR) genes in systemic sclerosis.

Authors:  P H Salim; M Jobim; M Bredemeier; J A B Chies; J Schlottfeldt; J C T Brenol; L F Jobim; R M Xavier
Journal:  Clin Exp Immunol       Date:  2010-01-15       Impact factor: 4.330

Review 9.  Interaction of NK inhibitory receptor genes with HLA-C and MHC class II alleles in Hepatitis C virus infection outcome.

Authors:  Viviana Romero; Jose Azocar; Joaquin Zúñiga; Olga P Clavijo; Daniel Terreros; Xiangjun Gu; Zaheed Husain; Raymond T Chung; Christopher Amos; Edmond J Yunis
Journal:  Mol Immunol       Date:  2008-03-04       Impact factor: 4.407

10.  KIR2DS2 as predictor of thrombocytopenia secondary to pegylated interferon-alpha therapy.

Authors:  A Rivero-Juarez; R Gonzalez; M Frias; B Manzanares-Martín; D Rodriguez-Cano; I Perez-Camacho; A Gordon; F Cuenca; A Camacho; J A Pineda; J Peña; A Rivero
Journal:  Pharmacogenomics J       Date:  2016-03-15       Impact factor: 3.550

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.